Inflammasome proteins as biomarkers of multiple sclerosis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The inflammasome is a multiprotein complex that contributes to the innate immune response in animal models of MS as well as in patients with the disease. Important to the care of patients with MS is the need for biomarkers that can predict disease onset, disease exacerbation, as well as response to treatment. In this study, we analyzed serum samples from 32 patients with MS and 120 age-matched controls, and provide receiver operator characteristic (ROC) curves with associated confidence intervals following analyses of serum samples from patients with MS, most of which had the relapsing-remitting form of the disease, and from healthy unaffected donors, and determine the sensitivity and specificity of inflammasome proteins as biomarkers of MS. We report that caspase-1 (1.662 ± 0.6024 difference between means), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) (407.5 ± 35.79), and interleukin (IL)-18 (78.53 + 17.86) were elevated in the serum of MS patients when compared to controls. Interestingly, the levels of IL-1ß (-0.5961 ± 0.265) were lower in the MS cohort. Importantly, the area under the curve (AUC) for ASC and caspase-1 were 0.9448 and 0.848, respectively. Taken together, these data suggest that ASC and caspase-1 could be potential candidate biomarkers for MS onset.

Original languageEnglish (US)
Article number135
JournalFrontiers in Neurology
Volume9
Issue numberMAR
DOIs
StatePublished - Mar 19 2018

Fingerprint

Inflammasomes
Multiple Sclerosis
Biomarkers
Caspase 1
Proteins
Serum
Multiprotein Complexes
Interleukin-18
Interleukin-1
Innate Immunity
Autoimmune Diseases
Area Under Curve
Disease Progression
Spinal Cord
Patient Care
Animal Models
Tissue Donors
Confidence Intervals
Apoptosis
Sensitivity and Specificity

Keywords

  • Apoptosis-associated speck-like protein containing a caspase recruitment domain
  • Biomarkers
  • Caspase-1
  • Inflammasome
  • Multiple sclerosis
  • Serum

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{e05ac369d1d4497494a4d1713752a807,
title = "Inflammasome proteins as biomarkers of multiple sclerosis",
abstract = "Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The inflammasome is a multiprotein complex that contributes to the innate immune response in animal models of MS as well as in patients with the disease. Important to the care of patients with MS is the need for biomarkers that can predict disease onset, disease exacerbation, as well as response to treatment. In this study, we analyzed serum samples from 32 patients with MS and 120 age-matched controls, and provide receiver operator characteristic (ROC) curves with associated confidence intervals following analyses of serum samples from patients with MS, most of which had the relapsing-remitting form of the disease, and from healthy unaffected donors, and determine the sensitivity and specificity of inflammasome proteins as biomarkers of MS. We report that caspase-1 (1.662 ± 0.6024 difference between means), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) (407.5 ± 35.79), and interleukin (IL)-18 (78.53 + 17.86) were elevated in the serum of MS patients when compared to controls. Interestingly, the levels of IL-1{\ss} (-0.5961 ± 0.265) were lower in the MS cohort. Importantly, the area under the curve (AUC) for ASC and caspase-1 were 0.9448 and 0.848, respectively. Taken together, these data suggest that ASC and caspase-1 could be potential candidate biomarkers for MS onset.",
keywords = "Apoptosis-associated speck-like protein containing a caspase recruitment domain, Biomarkers, Caspase-1, Inflammasome, Multiple sclerosis, Serum",
author = "Robert Keane and {Dalton Dietrich}, W. and {de Rivero Vaccari}, {Juan Pablo P}",
year = "2018",
month = "3",
day = "19",
doi = "10.3389/fneur.2018.00135",
language = "English (US)",
volume = "9",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "MAR",

}

TY - JOUR

T1 - Inflammasome proteins as biomarkers of multiple sclerosis

AU - Keane, Robert

AU - Dalton Dietrich, W.

AU - de Rivero Vaccari, Juan Pablo P

PY - 2018/3/19

Y1 - 2018/3/19

N2 - Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The inflammasome is a multiprotein complex that contributes to the innate immune response in animal models of MS as well as in patients with the disease. Important to the care of patients with MS is the need for biomarkers that can predict disease onset, disease exacerbation, as well as response to treatment. In this study, we analyzed serum samples from 32 patients with MS and 120 age-matched controls, and provide receiver operator characteristic (ROC) curves with associated confidence intervals following analyses of serum samples from patients with MS, most of which had the relapsing-remitting form of the disease, and from healthy unaffected donors, and determine the sensitivity and specificity of inflammasome proteins as biomarkers of MS. We report that caspase-1 (1.662 ± 0.6024 difference between means), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) (407.5 ± 35.79), and interleukin (IL)-18 (78.53 + 17.86) were elevated in the serum of MS patients when compared to controls. Interestingly, the levels of IL-1ß (-0.5961 ± 0.265) were lower in the MS cohort. Importantly, the area under the curve (AUC) for ASC and caspase-1 were 0.9448 and 0.848, respectively. Taken together, these data suggest that ASC and caspase-1 could be potential candidate biomarkers for MS onset.

AB - Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord. The inflammasome is a multiprotein complex that contributes to the innate immune response in animal models of MS as well as in patients with the disease. Important to the care of patients with MS is the need for biomarkers that can predict disease onset, disease exacerbation, as well as response to treatment. In this study, we analyzed serum samples from 32 patients with MS and 120 age-matched controls, and provide receiver operator characteristic (ROC) curves with associated confidence intervals following analyses of serum samples from patients with MS, most of which had the relapsing-remitting form of the disease, and from healthy unaffected donors, and determine the sensitivity and specificity of inflammasome proteins as biomarkers of MS. We report that caspase-1 (1.662 ± 0.6024 difference between means), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) (407.5 ± 35.79), and interleukin (IL)-18 (78.53 + 17.86) were elevated in the serum of MS patients when compared to controls. Interestingly, the levels of IL-1ß (-0.5961 ± 0.265) were lower in the MS cohort. Importantly, the area under the curve (AUC) for ASC and caspase-1 were 0.9448 and 0.848, respectively. Taken together, these data suggest that ASC and caspase-1 could be potential candidate biomarkers for MS onset.

KW - Apoptosis-associated speck-like protein containing a caspase recruitment domain

KW - Biomarkers

KW - Caspase-1

KW - Inflammasome

KW - Multiple sclerosis

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=85044159829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044159829&partnerID=8YFLogxK

U2 - 10.3389/fneur.2018.00135

DO - 10.3389/fneur.2018.00135

M3 - Article

AN - SCOPUS:85044159829

VL - 9

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - MAR

M1 - 135

ER -